Your browser doesn't support javascript.
loading
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism and Enduring Risk Factors: Rationale and Design of the HI-PRO Trial.
Bikdeli, Behnood; Hogan, Heather; Morrison, Ruth B; Fanikos, John; Campia, Umberto; Barns, Briana M; Pfeferman, Mariana B; Snyder, Julia E; Khairani, Candrika D; Goldhaber, Samuel Z; Piazza, Gregory.
Affiliation
  • Bikdeli B; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Hogan H; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Morrison RB; Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut, United States.
  • Fanikos J; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, United States.
  • Campia U; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Barns BM; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Pfeferman MB; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Snyder JE; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Khairani CD; Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Goldhaber SZ; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Piazza G; Department of Pharmacy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Thromb Haemost ; 122(6): 1061-1070, 2022 06.
Article in En | MEDLINE | ID: mdl-34530470

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Embolism / Venous Thromboembolism Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Thromb Haemost Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Embolism / Venous Thromboembolism Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Thromb Haemost Year: 2022 Document type: Article Affiliation country: